Quantitative Imaging Metrics From CECT in Measuring Disease Response or Progression in Patients With Kidney Cancer

Completed

Conditions studied: Renal Cell Carcinoma

In brief

This pilot research trial studies quantitative imaging metrics derived from contrast enhanced computed tomography (CECT) in enhancing assessment of disease status in patients with kidney cancer. Quantitative imaging is the extraction of quantifiable features from radiological images for the assessment of disease status. Collecting quantitative imaging metrics from CECT imaging may help doctors predict tumor aggressiveness and nuclear grade (tumor stage) and assess treatment response and prognosis in cancer imaging.

Key facts

Study ID

NCT02370290

Run by

University of Southern California

People needed

74

Starts

2014-04-01

Expected to finish

2016-02-01

Last updated by the study team

2016-03-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects with a renal mass who are scheduled for surgery for presumed RCC
• Subjects scheduled for standard of care contrast enhanced CT examination at USC Norris Comprehensive Cancer Center
• Subjects competent to sign study specific written informed consent

You may not qualify if…

• Subjects who are pregnant
• Subjects who cannot consent for themselves

Where it is running

• USC Norris Comprehensive Cancer Center — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.